THE 5-SECOND TRICK FOR AZELAPRAG CLINICAL TRIALS

The biotech sought to bear this system out in STRIDES, a mid-stage, randomized, double-blinded and placebo-controlled trial that evaluated the efficacy and basic safety of azelaprag—with and with out Eli Lilly’s blockbuster incretin treatment method tirzepatide—in over 200 individuals with obesity.” BioAge remains self-assured in azelaprag